• FDA Compounding Panel Backs 6 of 7 Peptides Despite Safety Risks in Oversight and Production

    FDA Compounding Panel Backs 6 of 7 Peptides Despite Safety Risks in Oversight and Production
    By Gina Shaw Rita Jew, PharmDThe FDA Pharmacy Compounding Advisory Committee’s (PCAC’s) recommendation that six of seven peptides be added to the 503A bulk drug substances list has alarmed leading medication safety experts.The move departs from the evidence-based process the agency normally follows and leaves several unresolved safety questions in place, noted Rita Jew, PharmD, the president of the Institute for Safe Medication Practices (ISMP), part of ECRI. Demand for peptide produ
  • FDA Approves Zilucoplan Once-Daily Autoinjector for Generalized Myasthenia Gravis

    FDA Approves Zilucoplan Once-Daily Autoinjector for Generalized Myasthenia Gravis
    By PPN StaffThe FDA has approved zilucoplan (Zilbrysq, UCB) for the treatment of generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor antibody–positive.Zilucoplan is the first self-administered, once-daily autoinjector administration option for this form of gMG. The autoinjector is designed to automatically deliver a predetermined dose when activated against the skin to ease the self-administration process.“For a chronic condition like gMG, having differe
  • Does a Designated Pharmacist Improve OPAT Outcomes?

    Does a Designated Pharmacist Improve OPAT Outcomes?
    By Meaghan Lee Callaghan and Landon GrayDoes including a designated pharmacist in managing outpatient parenteral antimicrobial therapy (OPAT) improve patient outcomes?A new study presented at MAD-ID x SIDP 2026 suggests yes, but more research is needed.Study authors Meg Parmalee, PharmD, a PGY-2 oncology pharmacy resident, and Tamanna Talwar, PharmD, a PGY-1 ambulatory pharmacy resident, both at UNC Health, in Chapel Hill, North Carolina, spoke with Infectious Disease Special Edition at the conf
  • AXS26 Panel: Keep Cybersecurity Top of Mind

    AXS26 Panel: Keep Cybersecurity Top of Mind
    Originally published by our sister publication Specialty Pharmacy ContinuumBy Marcus A. BanksRansomware attacks that prevent e-prescribing and firewall breaches that provide a direct line to protected health information are among cybersecurity risks pharmacists face daily, whether operating independently, within a chain, or in a health system. Speakers at Asembia’s AXS26 Summit, in Las Vegas, stressed the importance of cybersecurity strategy.“As a pharmacist myself, I know how comple
  • Advertisement

Follow @newsl_pharmacy on Twitter!